196 related articles for article (PubMed ID: 38239047)
1. Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift.
Tantawy MN; McIntyre JO; Yull F; Calcutt MW; Koktysh DS; Wilson AJ; Zu Z; Nyman J; Rhoades J; Peterson TE; Colvin D; McCawley LJ; Rook JM; Fingleton B; Crispens MA; Alvarez RD; Gore JC
Cancer Med; 2024 Feb; 13(3):e6812. PubMed ID: 38239047
[TBL] [Abstract][Full Text] [Related]
2. Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.
Felix DD; Gore JC; Yankeelov TE; Peterson TE; Barnes S; Whisenant J; Weis J; Shoukouhi S; Virostko J; Nickels M; McIntyre JO; Sanders M; Abramson V; Tantawy MN
Nucl Med Biol; 2015 Mar; 42(3):269-73. PubMed ID: 25533764
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
Kang F; Ma W; Ma X; Shao Y; Yang W; Chen X; Li L; Wang J
J Nucl Med; 2014 Mar; 55(3):439-45. PubMed ID: 24504055
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
McLarty K; Fasih A; Scollard DA; Done SJ; Vines DC; Green DE; Costantini DL; Reilly RM
J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in breast cancer following immunotherapy.
Hoffmann E; Schache D; Höltke C; Soltwisch J; Niland S; Krähling T; Bergander K; Grewer M; Geyer C; Groeneweg L; Eble JA; Vogl T; Roth J; Heindel W; Maus B; Helfen A; Faber C; Wildgruber M; Gerwing M; Hoerr V
J Transl Med; 2023 Aug; 21(1):577. PubMed ID: 37641066
[TBL] [Abstract][Full Text] [Related]
7. An Approach to Breast Cancer Diagnosis via PET Imaging of Microcalcifications Using (18)F-NaF.
Wilson GH; Gore JC; Yankeelov TE; Barnes S; Peterson TE; True JM; Shokouhi S; McIntyre JO; Sanders M; Abramson V; Ngyuen TQ; Mahadevan-Jansen A; Tantawy MN
J Nucl Med; 2014 Jul; 55(7):1138-43. PubMed ID: 24833491
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of Radioiodine-Labeled pH (Low) Insertion Peptide Variant 7-Like Peptide as a Noninvasive Tumor Microenvironment Imaging Agent in a Mouse MDA-MB-231 Triple-Negative Breast Cancer Model.
Wu F; Chen Y; Li D; Wang Z; Yu M
Mol Imaging Biol; 2022 Aug; 24(4):570-579. PubMed ID: 35006491
[TBL] [Abstract][Full Text] [Related]
9.
Liu H; Sun H; Zhang B; Liu S; Deng S; Weng Z; Zuo B; Yang J; He Y
Breast Cancer; 2020 May; 27(3):372-380. PubMed ID: 31781983
[TBL] [Abstract][Full Text] [Related]
10. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF
J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive
Henry KE; Dilling TR; Abdel-Atti D; Edwards KJ; Evans MJ; Lewis JS
J Nucl Med; 2018 Jan; 59(1):51-57. PubMed ID: 28848040
[TBL] [Abstract][Full Text] [Related]
12. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
[TBL] [Abstract][Full Text] [Related]
13. Lactic Acid Accumulation in the Tumor Microenvironment Suppresses
Türkcan S; Kiru L; Naczynski DJ; Sasportas LS; Pratx G
Cancer Res; 2019 Jan; 79(2):410-419. PubMed ID: 30510121
[TBL] [Abstract][Full Text] [Related]
14. Panitumumab-DOTA-
Facca VJ; Cai Z; Gopal NEK; Reilly RM
Mol Pharm; 2022 Oct; 19(10):3652-3663. PubMed ID: 35926098
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Imaging of Tumor Metabolism and Acidosis by Combining PET and MRI-CEST pH Imaging.
Longo DL; Bartoli A; Consolino L; Bardini P; Arena F; Schwaiger M; Aime S
Cancer Res; 2016 Nov; 76(22):6463-6470. PubMed ID: 27651313
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
[TBL] [Abstract][Full Text] [Related]
17. GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[
Capozza M; Anemone A; Dhakan C; Della Peruta M; Bracesco M; Zullino S; Villano D; Terreno E; Longo DL; Aime S
Mol Imaging Biol; 2022 Feb; 24(1):126-134. PubMed ID: 34383241
[TBL] [Abstract][Full Text] [Related]
18. AKT-dependent sugar addiction by benzyl isothiocyanate in breast cancer cells.
Roy R; Hahm ER; White AG; Anderson CJ; Singh SV
Mol Carcinog; 2019 Jun; 58(6):996-1007. PubMed ID: 30720225
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer.
Chen Y; Sun J; Luo Y; Liu J; Wang X; Feng R; Huang J; Du H; Li Q; Tan J; Ren G; Wang X; Li H
J Transl Med; 2022 Dec; 20(1):615. PubMed ID: 36564797
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]